¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sucrose density gradient"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • nodular density
    °áÀýÀ½¿µ
  • optical density
    1. ±¤Çйеµ 2. Èí±¤µµ
  • pixel density
    È­¼ÒÀ½¿µ, Çȼ¿À½¿µ
  • population density
    Àα¸¹Ðµµ
  • proton density contrast
    ¾ç¼ºÀڹеµ´ëÁ¶
  • proton density weighted image
    ¾ç¼ºÀڹеµ°­Á¶¿µ»ó
  • spin density
    ½ºÇɹеµ
  • spin density weighted image
    ½ºÇɹеµ°­Á¶¿µ»ó
  • shadow density
    ±×¸²ÀÚÀ½¿µ, Åõ¿µÀ½¿µ
  • very low density lipoprotein
    ÃÊÀú¹ÐµµÁöÁú´Ü¹éÁú
  • axial gradient
    üÃà±â¿ï±â, üÃà°æ»ç
  • active gradient shielding
    ´Éµ¿°æ»çÂ÷Æó
  • alveolar-arterial oxygen gradient
    ÆóÆ÷µ¿¸Æ°£»ê¼ÒºÐ¾ÐÂ÷
  • B1 field gradient
    ȸÀüÀÚÀå±â¿ï±â
  • background gradient
    ¹è°æ±â¿ï±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pixel density
    È­¼ÒÀ½¿µ, Çȼ¿À½¿µ
  • population density
    Àα¸¹Ðµµ
  • probability density
    È®·ü¹Ðµµ
  • proton density
    ¾çÀڹеµ
  • reticular density
    ¸Á»óÀ½¿µ, ±×¹°À½¿µ
  • shadow density
    À½¿µ¹Ðµµ
  • spin density
    ½ºÇɹеµ
  • high-density lipoprotein
    °í¹ÐµµÁöÁú´Ü¹é
  • intermediate density lipoprotein
    Á߹еµÁöÁú´Ü¹é
  • proton density weighted image
    ¾çÀڹеµ°­Á¶¿µ»ó
  • spin density weighted image
    ½ºÇɹеµ°­Á¶¿µ»ó
  • active gradient shielding
    ´Éµ¿±â¿ï±âÂ÷Æó, ´Éµ¿°æ»çÂ÷Æó
  • alveolar-arterial oxygen gradient
    ÆóÆ÷µ¿¸Æ°£»ê¼ÒºÐ¾ÐÂ÷
  • axial gradient
    üÃà±â¿ï±â, üÃà°æ»ç
  • gradient refocused acquisition
    ±â¿ï±âÀçÃÊÁ¡È¹µæ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • alveolar-arterial oxygen gradient
    ÆóÆ÷µ¿¸Æ°£ »ê¼ÒºÐ¾ÐÂ÷
  • frequency encoding gradient
    Á֯ļö ºÎȣȭ °æ»ç
  • gradient induced phase shift effect
    °æ»ç À¯µµ À§»ó º¯À§ È¿°ú
  • gradient limiting reabsorption
    ³óµµÁõ°¨Á¦ ÇѼº ÀçÈí¼ö.
  • gradient magnetic coil
    °æ»ç ÀÚ±â ÄÚÀÏ
  • gradient magnetic field
    °æ»ç ÀÚ±âÀå
  • gradient method
    °è´ÜÀû°Ë»ç¹ý
  • gradient moment
    °æ»ç ¸ð¸àÆ®
  • gradient moment nulling (GMN)
    °æ»ç ¸ð¸àÆ® ¹«È¿È­
  • gradient motion rephasing (GMR)
    °æ»ç ¿îµ¿ ÀçÀ§»ó
  • gradient recalled echo
    °æ»ç ȸº¹ ¿¡ÄÚ
  • gradient refocused acquisition
    °æ»ç ÀçÃÊÁ¡ ȹµæ
  • gradient refocused imaging
    °æ»ç ÀçÃÊÁ¡ ¿µ»ó
  • gradient shielding
    °æ»ç Â÷Æó
  • gradient slope
    °æ»ç ±â¿ï±â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • density, epitope
    Ç׿ø°áÁ¤±â¹Ðµµ
  • density, optical
    Èí±¤µµ
  • electron density
    ÀüÀڹеµ
  • electron density
    ÀüÀڹеµ(¡­ÚËöô).
  • energy flux density
    ¿¡³ÊÁö¼Ó¹Ðµµ
  • epitope density
    Ç׿ø°áÁ¤±â¹Ðµµ
  • familial high density lipoprotein def
    °¡Á·¼º °íºñÁ߸®Æ÷´Ü¹éÁú°áÇÌ Áõ.
  • flux density
    À¯µ¿ ¹Ðµµ
  • flux density
    ¼Ó¹Ðµµ
  • grain density
    ÀÔÀÚ<±×·¡ÀÎ>¹Ðµµ.
  • high electron density
    °íÀüÀڹеµ(ÍÔï³í­ÚËöô).
  • high-density lipoprotein
    °í¹ÐµµÁö¹æ´Ü¹é
  • incidence density
    ¹ß»ý ºóµµ
  • innervation density
    ½Å°æÁö¹è¹Ðµµ(¡­ÚËöô).
  • intermediate density lipoprotein =IDL ´ç´¢
    Áß°£ºñÁßÁö(Áú)´Ü¹é(Áú).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • convex exponential gradient
    º¼·Ï Áö¼ö ±¸¹è(ò¦â¦ÎþÛÕ)
  • fluidity gradient
    À¯µ¿¼º ±¸¹è(×µÔÑàõÎþÛÕ)
  • gradient
    ±¸¹è(ÎþÛÕ)
  • gradient-coupled active transport
    ±¸¹è(ÎþÛÕ) ¦Áø ´Éµ¿¼ö¼Û(ÒöÔÑâÃáê)
  • gradient curve
    ±¸¹è °î¼±(ÎþÛÕÍØàÊ)
  • gradient elution
    ±¸¹è ¿ë¸®(ÎþÛÕéÁ×î)
  • gradient-flow method
    ±¸¹è(ÎþÛÕ)-È帧¹ý(Ûö)
  • gradient gel electrophoresis
    ±¸¹è(ÎþÛÕ) Á© Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ)
  • gradient layer
    ±¸¹èÃþ(ÎþÛÕöµ)
  • gradient mixer
    ±¸¹è È¥ÇÕ±â(ÎþÛÕûèùêÐï)
  • gradient plate technique
    ±¸¹è ÆÇ(ÎþÛÕ÷ù)¼ú(âú)
  • gradient sievorptive chromatography
    ±¸¹è ¿©°úÈíÂø(ÎþÛÕÕëΦýåó·) Å©·Î¸¶Åä±×·¡ÇÇ
  • isokinetic gradient
    µî¿ªÇÐ ±¸¹è(ÔõÕôùÊÎøÛÎ)
  • isopycnic gradient centrifugation
    µî¹Ðµµ±¸¹è¿ø½ÉºÐ¸®(ÔõÚËÓøÎøÛÎêÀãýÝÂ×î)
  • pH gradient electrophoresis
    pH ±¸¹è Àü±â¿µµ¿(ÎþÛÕï³Ñ¨ç¶ÔÑ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • diffusion gradient pulse
    È®»ê°æ»çÆÞ½º
  • fast gradient recalled echo method
    °í¼Ó°æ»çȸº¹¿¡ÄÚ±â¹ý
  • fast multiplanar spoiled gradient recalled sequence
    °í¼Ó´Ù¸éȸ¼Õ°æ»çȸº¹¿¬¼â
  • field gradient
    ÀÚÀå°æ»ç
  • flow compensation gradient technique
    À¯µ¿º¸»ó°æ»ç±â¹ý
  • flow sensitive gradient echo sequence
    À¯µ¿¹Î°¨°æ»ç¿¡ÄÚ¿¬¼â
  • frequency encoding gradient
    Á֯ļöºÎȣȭ°æ»ç
  • gradient
    °æ»ç
  • gradient acquisition imaging
    °æ»çȹµæ¿µ»ó
  • gradient coil
    °æ»çÄÚÀÏ
  • gradient echo [=GRE]
    °æ»ç¿¡ÄÚ
  • gradient echo [=GRE] imaging
    °æ»ç¿¡ÄÚ¿µ»ó
  • gradient echo [=GRE] pulse sequence
    °æ»ç¿¡ÄÚÆÞ½º¿¬¼â
  • gradient echo effect
    °æ»ç¿¡ÄÚÈ¿°ú
  • gradient echo sequence
    °æ»ç¿¡ÄÚ¿¬¼â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
AAG 3-alkaladenine deoxyribonucleic acid glycosylase; allergic angiitis and granulomatosis; alpha-1-acid...
CGGE constant gradient gel electrophoresis
DGGE denaturating gradient gel electrophoresis
ECPOG electrochemical potential gradient
GE gastric empyting; gastroemotional; gastroenteritis; gastroenterology; gastroenterostomy; gastroesoph...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
TCBS thiosulfate citrate bile salt sucrose
AaDO2 Alveolar-arterial oxygen gradient
DGGE Denaturing Gradient Gel Electrophoresis
GE Gradient Echo
GRE Gradient Echo
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • high-density lipoprotein
    °í¹Ðµµ Áö¹æ ´Ü¹é
  • low-density lipoprotein
    Àú¹Ðµµ Áö¹æ ´Ü¹é
  • magnetic flux density
    ÀÚ±â À¯µ¿ ¹Ðµµ
  • minimum useful density
    ÃÖ¼Ò À¯È¿ ³óµµ
  • mosquito density
    ¸ð±â ¹Ðµµ
  • nodular density
    °áÀý¼º À½¿µ
  • perihilar density
    Æó¹® ÁÖÀ§ À½¿µ
  • photographic density
    »çÁø ÈæÈ­µµ
  • pixel density
    Çȼ¿ À½¿µ, È­¼Ò À½¿µ
  • power density
    Ãâ·Â ¹Ðµµ
    ÀÏÁ¤ Ç¥¸é¿¡ ´ëÇÑ ·¹ÀÌÀú Ãâ·ÂÀÇ ºÐÆ÷ ÃøÁ¤. Ãâ·Â ¹Ðµµ¸¦ À§ÇÑ ´ÜÀ§´Â ÀüÇüÀûÀ¸·Î ÀÏÁ¤ Ç¥¸é ȤÀº ÃÊÁ¡ Å©±â¿¡ ´ëÇÑ 1cm
  • proton density contrast
    ¾çÀÚ ¹Ðµµ ´ëÁ¶
  • proton density weighting
    ¾çÀÚ °­Á¶
  • proton spin density
    ¾çÀÚ ¹Ðµµ
  • reticular density
    ¸Á»ó À½¿µ
  • spin density weighted image
    ½ºÇÉ ¹Ðµµ °­Á¶ ¿µ»ó
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
buoyant density The density that allows a substance to float in some standard fluid.
(05 Mar 2000)
vapor density The mass per unit volume of a vapor; since the vapor density changes with temperature and pressure, it is commonly expressed as a specific gravity, i.e., the weight of the vapor divided by the weight of an equal volume of a reference gas (e.g., oxygen or hydrogen) at the same temperature and pressure.
(05 Mar 2000)
very low density lipoprotein <biochemistry> A lipoprotein substances (combination of a fat and a protein) which acts as a carrier for cholesterol and fats (particularly triglycerides) in the bloodstream.
Elevations in very low density lipoprotein in the bloodstream are associated with an increased risk of atherosclerosis and coronary artery disease.
Acronym: VLDL
(18 Nov 1997)
photon density The number of counted events recorded in scintigraphy per square centimeter or per square inch of imaged area.
Synonym: count density.
(05 Mar 2000)
count density The number of counted events recorded in scintigraphy per square centimeter or per square inch of imaged area.
Synonym: count density.
(05 Mar 2000)
population density <epidemiology> Number of individuals in a population relative to space.
(12 Dec 1998)
current density <radiobiology> Amount of current flowing through a substance, per unit area perpendicular to the direction of current flow. (See also density)
(09 Oct 1997)
high density lipoprotein <biochemistry> These lipoproteins acts to carry cholesterol in the bloodstream.
Raised high density lipoprotein levels have been correlated with a lower risk for heart disease. Less than 35 mg/dl is considered a positive risk factor for coronary artery disease, over 60 mg/dl is considered a negative risk factor (reduces your risk of heart disease).
Recent studies show a low high density lipoprotein level is the strongest predictor of cardiovascular death in women.
Acronym: HDL
(18 Nov 1997)
spin density The number of nuclear dipoles per unit volume.
(05 Mar 2000)
stand density The number or mass of trees occupying a site. It is usually measured in terms of stand density index or basal area per acre.
(05 Dec 1998)
neutral-density filter <equipment> A light-absorbing filter whose absorption spectrum is moderately flat. Depending on the type, the absorption curve is flat primarily in the visible spectral range, or may extend to varying degrees beyond the visible range. For video microscopy, this is an important point since the absorbance may or may not extend into the near-infrared region where the sensitivity of many video image pickup devices is very high.
(05 Aug 1998)
density 1. <radiology> The amount of darkness or light in an area of a scan reflects the compactness and density of tissue. Differences in tissue density are the basis for CT and MR scans.
2. <microscopy> Logarithm to the base 10 of the reciprocal of transmittance.
(12 Jan 1998)
density-dependent <epidemiology> 1. Effects whose intensity changes with increasing population density.
2. Effects whose intensity increases with increasing population density, for example a mortality which becomes very high near a carrying capacity. Effects which become less pronounced at higher population sizes (perhaps the reduction in fecundity caused by the difficulty of mating) are sometimes called inverse density dependent. Density dependent effects are often a cause of nonlinearity in a model.
(05 Dec 1998)
density dependent inhibition of growth <cell culture> The phenomenon exhibited by most normal (anchorage dependent) animal cells in culture that stop dividing once a critical cell density is reached.
The critical density is considerably higher for most cells than the density at which a monolayer is formed, for this reason, most cell behaviourists prefer the term density dependent inhibition of growth as this avoids any confusion with contact inhibition of locomotion, a totally different phenomenon that is contact dependent.
(12 Jan 1998)
incidence density The person-time incidence rate.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á